Vidofludimus Calcium for Primary Sclerosing Cholangitis
- First Posted Date
- 2018-10-29
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Elizabeth Carey
- Target Recruit Count
- 18
- Registration Number
- NCT03722576
- Locations
- ๐บ๐ธ
Mayo Clinic in Arizona, Phoenix, Arizona, United States
๐บ๐ธArizona State University, Tempe, Arizona, United States
๐บ๐ธMayo Clinic in Rochester, Rochester, Minnesota, United States
Vancomycin for Primary Sclerosing Cholangitis
Phase 2
Active, not recruiting
- Conditions
- Primary Sclerosing Cholangitis
- Interventions
- Other: PlaceboDrug: Vancomycin
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Elizabeth Carey
- Target Recruit Count
- 102
- Registration Number
- NCT03710122
- Locations
- ๐บ๐ธ
Mayo Clinic Florida, Jacksonville, Florida, United States
๐บ๐ธMayo Clinic Arizona, Phoenix, Arizona, United States
๐บ๐ธArizona State University, Tempe, Arizona, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath